The maintenance of T lymphocytes in vivo after adoptive transfer for immunotherapy requires the systemic administration of interleukin-2 (IL-2). but prolonged administration of IL-2 is associated with substantial toxicity. The constitutive production of IL-2 by T cells may be an alternative method to prolong T-cell survival and potentially augment antitumor responses. To study the effects of constitutive production of IL-2 on the growth and antigen reactivity of a murine T cell, the sperm-whale myoglobin ( S W ) specific T-cell line 14.1 was retrovirally transduced with the cDNA for IL-2. Cells that were transduced with vectors without an internal promoter were able to proliferate in the absence of exogenously added IL-2, and to grow in an autocrine fashion. These vectors used an internal ribosomal entry site (IRES) NTERLEUKIN-2 (IL-2) is a central mediator of the growth and function of T Studies have shown that the systemic administration IL-2 may result in antitumor responses both in murine tumor models as well as in patients with ~a n c e r .~.~ Furthermore, IL-2 has been used to stimulate the ex vivo proliferation and growth of immune effector cells, including tumor-infiltrating lymphocytes (TIL), which have specific lytic activity against autologous
The concomitant administration of IL-2 is required for the efficacy of adoptively transferred TIL, most likely because the ex vivo generation of effectors uses high concentrations of IL-2 and results in a dependency of the cells for exogenous IL-2. Indeed, studies using TIL that have been marked by retroviral transduction with the neomycin phosphoribosyl transferase gene (neo') have shown that the cells are often no longer detectable shortly after the discontinuation of systemic L -2 treatment.' The high levels of IL-2 required for therapy are associated with significant toxicity, including hypotension, which limits the duration of E -2 adrnini~tration.4,~ Insertion of the L -2 gene into the effector cells may allow for continued growth of the T cells in the absence of exogenous IL-2.9."
Despite the ability of IL-2 to function as a T-cell growth factor, IL-2 also functions as an immunoregulatory factor in T cells and can limit responsiveness of T cells to antigen." Interaction of lymphocytes that are proliferating in response to L -2 with antigen may result in apoptosis of the cells.'* Thus, the autocrine production of L -2 by T cells could result in functional defects. To study the effects of the constitutive production of IL-2 by T cells could result in functional defects. To study the effects of the constitutive production of IL-2 by T cells on their growth and antigen reactivity, the sperm-whale myoglobin (SWM) specific murine T-cell line 14.113 was retrovirally transduced with the cDNA for IL-2. After G418 selection, cells grew continuously in an autocrine fashion in the absence of exogenous IL-2. The transduced cells retained specific antigen reactivity. These results confirm previous report^^^'^ that the constitutive production of IL-2 may allow the prolonged growth of T cells in the absence of IL-2 supplementation and extend these studies by showing that T-cell antigen reactivity is maintained in these cells.
ral packaging cell line GP + E86I6 (kindly provided by Dr A. Bank, Columbia University, New York, NY), and the amphotropic retroviral packaging cell line PA317" (American Type Culture Collection [ATCC], Rockville, MD) were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FCS, glutamine (2 mmoVL), penicillin (100 UlmL), and streptomycin ( 1 0 0 pglmL) (all from Biofluids, Inc, Rockville, MD). Retroviral producer lines were made by introduction of the IL-2 vectors by calcium phosphate transfection of a mixture of PA317 (2 X 10' cells) and GP + E86 cells (3 X IO5) in 100-mm dishes. High-titer G418-resistant clones were then selected.
Transduction oflyrnphocyres. The 14.1 cells were transduced by culture of the cells in fresh packaging cell supernatant containing polybrene (8 pglmL; Aldrich, Milwaukee, WI). Supernatant was always filtered through a 0.22-pm cellulose acetate filter (Coming, Coming, NY) before use to eliminate cellular contaminants. After 16 hours, the cells were incubated an additional 8 hours in fresh supernatant, then were pelleted and resuspended in fresh medium. After 24 hours, the cells were selected by culture in medium containing G418 (0.8 to 1 mg/mL; Life Technologies, Rockville, MD) for 7 to 10 days.
Proliferation assay. T cells were washed and resuspended in fresh medium and cultured at 1 X lo" cellslwell in 96-well flatbottom plates. For inhibition studies, cells were cultured in medium alone or with either an antimurine IL-2 receptor a (mlL-2Ra) antibody (3C7.250 pglmL)," a neutralizing antibody against human IL-2 (R&D Systems, Minneapolis, MN), or an antihuman IL-4 antibody (1 1BI 1, 250 pg/mL).'9 After 24 hours 2 pCi of 'H-thymidine was added to each well, and after an additional 4-hour culture, the cells were harvested onto fiber paper using an automated cell harvester (Wallac, Uppsula, Sweden), and radioactive uptake measured using a scintillation counter (Wallac).
IL-2 assay. The 14.1 cells were washed thoroughly with phosphate-buffered saline (PBS) before culture. Cells (1 X IO6) were incubated in fresh medium, or medium containing either an antimurine IL-2 receptor antibody (3C7.250 pg/mL)" or a control antibody (1 1B11, 250 pglmL)." After 72 hours, the supernatants were aspirated, centrifuged at 2,000 rpm, decanted, and frozen at -20°C. Frozen aliquots were analyzed using a human IL-2 enzyme-linked immunosorbent assay (ELISA; R & D Systems, Minneapolis, MN) and the values determined by comparing samples to known standards provided with the assay.
Norrhern hybridization. Total cellular RNA was extracted by the guanidine-isothiocyanate technique and run in 20-pg aliquots on a 1% denaturing agarose gel containing 2.2 molL formaldehyde. RNA was transferred to nylon membranes (Duralon UV; Stratagene, La Jolla, CA) using positive pressure, UV-cross linked, and hybridized at 68°C in QuikHyb (Stratagene) according to the manufacturer's protocols. Full-length cDNA template used as a probe for neo' was radiolabeled with "P-labeled dCTP by random primer extension to a high specific activity ( > l X IO9 dpdpg). After hybridization, membranes were washed and filters were imaged by autoradiography using Kodak XAR film (Eastman Kodak, Rochester, NY).
Lymphocyte stimulation and interferon-y (IFN-y ) assay. After washing with PBS, 2.5 X l @ 14.1 cells were cocultured with 2.5 X IO6 BALBlc splenocytes in the presence or absence of SWM (4 pmolL) or ovalbumin (71 pg/mL) (both from Sigma Chemical CO, St Louis, MO). The 14.1 cells were also stimulated with anti-CD3 (2Cll; Pharmingen. San Diego, CA) which was precoated for 16 hours onto wells of a 24-well plate using a 4-pglmL solution in bicarbonate buffer. After 24 hours, the supernatants were aspirated, centrifuged at 2,000 RPM to remove cells and debris, decanted, and stored at -20°C. Thawed aliquots were tested in an ELBA for murine IFN-y (Endogen, Inc. Boston, MA) and values determined by comparing the samples with known standards included in the assay.
Animal studies. Female BALBlc mice were approximately 8 weeks old at the time of use. The 14. I cells were washed three times in PBS, resuspended in Hank's Balanced Salt Solution (HBSS), and inoculated subcutaneously in a 0.2-mL volume on the abdomen using a 26-gauge needle.
RESULTS

Retroviral construction.
Retroviral-based vectors were used because they offer the advantage of high-efficiency gene transfer and stable integration of the gene. In all three of the retroviral constructs, the cDNA coding for IL-2 was under the transcriptional control of the MMLV long-terminal repeat (LTR). In all three retroviral vectors, the 3' AU-rich untranslated region of the IL-2 cDNA was deleted, because it is known to be associated with decreased mRNA stability." As shown in The wild-type retroviral RNA is spliced to allow for the expression of the envelope gene message, with the splice acceptor site present in the pol region of the virus. The pol region has been removed in the retroviral vectors, and thus the splice acceptor site is not present in either the LXSN and pGlEN vectors. To try to maximize translation, the splice acceptor site (SA) was reinserted into the IRES vector by PCR amplification of the SA and the flanking regions of MMLV and insertion 5' to the cloning site of the pGlEN vector. The maximal titer obtained for the producer lines of the IRES-containing vectors was approximately 5-to 20-fold higher than that of the LXSN-based vector producer lines (Fig 1A) .
Retroviral RNA expression in the 14.1 cell line which were transduced with the IL-2 vectors and selected in G418 was studied by Northern blot analysis of total cellular RNA using neo' cDNA as a probe. As shown in Fig lB, an MMLV LTR-driven transcript was present in all three of the transduced cells. The levels of message appeared to be somewhat higher in cells transduced with the GIL-2EN and SAM-IL-2EN vectors. There was abundant levels of SV-40-driven transcript in the 14.1 transduced with LIL-2SN. A second band, slightly smaller than the LTR-driven transcript, was present in RNA from the 14.1 transduced with the SAM-IL-2EN vector, and most likely represents the spliced form of the LTR-driven transcript.
Proliferation of transduced lymphocytes. To determine the effect of transduction on the 14.1 cells, we first examined the responsiveness of the cells to IL-2 by proliferation assays. After transduction and selection of the lymphocytes in G418 for 10 days, the cells were washed and cultured at 1 X lo5 cells/well in medium alone or medium with IL-2 (150 IU/mL) for 3 or 7 days, and the proliferation of the cells was measured by 3H-thymidine incorporation. As shown in Fig 2, the level of 3H-thymidine uptake by the nontransduced 14.1 was minimal in the absence of exogenous IL-2. The 14.1 transduced with the L-IL-2SN construct also showed minimal proliferation in the absence of IL-2. By contrast, 14.1 transduced with either the GIL-2EN or SAM-IL-2EN proliferated in the absence of exogenously added IL-2. The proliferation of the 14.1-SAM-IL-2EN appeared to be greater than that of the 14.1 GIL-2EN. Similar proliferative responses were observed in experiments with cells from three separate transductions with these vectors.
Growth of IL-2-transduced cells.
The proliferation of the transduced 14.1 in the absence of exogenously added IL-2 suggested the potential for autocrine growth of these cells. To determine the autocrine growth of the lymphocytes, cells were washed with PBS and resuspended in fresh medium without IL-2 and growth of the cultures was measured. As shown in Fig 3A, both the GIL-2EN and SAM-IL-2EN-transduced 14.1 grew logarithmically in IL-2-free medium. Similar growth was measured in an independent experiment. The growth of the cells transduced with the SAM-IL-2EN vector paralleled that of the nontransduced 14.1 grown in medium with IL-2 ( Fig 3B) . No growth was observed by either the nontransduced cells or the LIL-2SN transduced cells when cultured in IL-2-free medium.
Inhibition of proliferation by antibodies to human IL-2 and the murine IL-2 receptor. To determine if the increased proliferation was actually a function of human IL-2 production, transduced cells that had been in continuous culture in medium without exogenous IL-2 for over 120 days were washed and cultured for 24 hours alone or in the presence of an antibody to human IL-2 (R&D Systems) or an antibody to the murine IL-2 receptor a chain (mIL-2R) (3C7). As shown in Fig 4, proliferation of the SAM-IL-2EN-transduced cells was inhibited by both the anti-IL-2 receptor antibody as well as the antibody for human IL-2, but not by a control antibody, 11B11, which recognizes murine IL-4.I9 An additional experiment showed similar inhibition. Proliferation of the GIL-2EN-transduced cells was similarly inhibited by these antibodies (data not shown).
IL-2 production by transduced 14.1. The proliferative response of the 14.1 suggested that the cells were constitutively producing IL-2. Because the human IL-2 ELISA does not cross-react with murine IL-2, the production of human IL-2 from the transgene can be specifically measured in the murine cell line 14.1. To determine the levels of IL-2 production, cells transduced with either the GIL-2-EN or SAM-IL-2EN vectors that had been cultured in recombinant human IL-2 free medium for over 60 days were assayed for human IL-2 by ELISA. The levels of human IL-2 in the supernatants after 72-hour incubation were detectable, although low (Table l) . Increased amounts of IL-2 were detected in the presence of the antimurine IL-2 receptor anti- body, 3C7," but not in the presence of a control antibody 11B 11 that recognizes IL-4I9 (both 3C7 and 11B 11 were a kind gift from Dr M.J. Lenardo, National Institute of Allergy and Infection Disease).
Antigen response of IL-2-transduced cells.
To determine the antigen responsiveness of 14.1 transduced with IL-2 cDNA, the cells grown for 90 days in the absence of IL-2 were stimulated with SWM presented on syngeneic splenocytes. As shown in Table 2 , the transduced cells responded to the SWM as measured by the production of IFNy and this response was specific for the antigen, because I m -y was not produced in response to splenocytes alone or splenocytes with ovalbumin. the tumorigenicity of lymphocytes.'~'"~2z To determine if the 14.1 growing in an autocrine fashion were similarly tumorigenic, cells (1 to 2.5 X 10'/mouse) were injected subcutaneously in the abdomen of syngeneic BALB/c mice. Tumor formation was not observed, even after prolonged observation (90 days), in either of two experiments with a total of seven mice in each group (data not shown). 
DISCUSSION
Adoptive cellular immunotherapy has been shown to produce sustained remissions of metastatic tumors in some cancer patients7 Such cells generally have been grown ex vivo in high concentrations of recombinant human IL-2 and require an exogenous source of IL-2 to maintain their viabilit^.^ Because the administration of systemic IL-2 is associated with substantial toxicity, alternative methods are being sought that can be used to maintain the growth of the cells after transfer to the patient. The production of IL-2 by a T cell may result in an autocrine loop, allowing continued growth of the cell. In the present studies we have shown that the introduction of the human XL-2 cDNA into murine T lymphocytes resulted in their sustained growth in the absence of exogenous IL-2. This was manifested both by proliferation after withdrawal of IL-2, as well as prolonged growth in the absence of exogenously added IL-2. In addition, these studies suggest that the production of IL-2 and autocrine growth does not impair the antigen reactivity of the cells.
The production of IL-2 by T cells is limited by the tightly controlled transcription of the IL-2 gene and the instability of its mRNA.20,23 In the vectors used in this study, the IL-2 gene was under the transcriptional control of the MMLV LTR, which should result in constitutive expression of the gene product. The 3' untranslated region of the gene was also deleted, because its presence is known to result in mRNA instability. The vectors used were also bicistronic, allowing the expression of both the IL-2 gene as well as the dominant selectable marker, neo'. In these studies there was a large difference in growth properties observed between the 14.1 cells transduced with the LIL-2SN vectors and the two IREScontaining vectors. The LIL-2SN construct contains an internal SV-40 promoter, which drives the transcription of the neor gene. By contrast, the two IRES vectors have only a single promoter, the MMLV LTR. The vectors code for a single transcript which contains an IRES to facilitate translation of the neo'. The adequate expression of neor is necessary because the efficiency of transduction of lymphocytes is Because all of the constructs use the MMLV LTR to drive transcription of the IL-2 gene, the differences between the growth of the selected cells implies that the SV-40 promoter may adversely affect LTR-driven transcription.
In the wild-type MMLV virus, the env region is transcribed by splicing of the gag and pol regions, with the splice acceptor present in the 3' region of the pol region of the virus. In the MMLV-based retroviral vectors, including the LXSN series of vectors, the env, pol and the majority of gag regions of the virus are deleted. Because the splice acceptor is in the pol sequence, it is also deleted in these vectors. This leaves multiple ATG sites 5' to the start site of the gene of interest, which could potentially act as translation start sites and interfere with gene expression. Although splicing can occur due to cryptic splice acceptor sites within the vector,I4 it may also interfere with gene expression by splicing within the gene sequence. The insertion of a splice acceptor 5' to the expressed gene, analogous to that present 5' to the env gene of the wild-type vector, might result in controlled splicing of the transcript. The pSAM-EN vector was made by placing the env gene splice acceptor and the adjacent sequence into the IRES-containing vector pG1EN. The pSAM-EN is similar to the MFG vector used by Dranoff et al,25 but the MFG vector does not contain a selectable marker. Another difference between the SAM-EN vector and the MFG vector is the elimination of the env start codon. This modification permits the use of the native start codon of the inserted gene, and greatly increases the utility of the SAM-EN vector. In addition, the lack of the MMLV env gene start codon decreases the potential that recombination between the vector and the packaging genome will generate replication competent helper virus.
The 14.1 transduced with the splice acceptor containing vector SAM-IL-2EN showed greater proliferation in IL-2-free medium than the cells transduced with a vector containing the IRES alone. The initial growth rate was also higher in the SAM-IL-2EN-transduced cells but the eventual growth rate was similar to that of the 14.1 transduced with GIL-2EN vector. This could be the effect of a higher titer of the SAM-IL-2EN supernatant resulting in a higher percentage of the cells transduced and thus fraction of expanding. However, even after G418 selection and 90 days in IL-2-free medium, the cells transduced with the SAM-IL-2EN vector produced larger amounts of IL-2 than did the 14.1 cells transduced with the GIL-2EN vector. Thus, the presence of the splice acceptor may provide for increased production of IL-2 by the transduced cells.
Despite the marked proliferation of the transduced lines in the absence of supplemented IL-2, the detected levels of secreted IL-2 were low. This was probably caused by the rapid uptake of the secreted IL-2 by the lymphocytes. Additionally, some of the cells may not have produced IL-2, but used IL-2 produced by other cells. To test if the proliferation of the transduced cells was due to autocrine production of For personal use only. on October 23, 2017. by guest www.bloodjournal.org From IL-2, cells were cultured in the presence of an antibody to the mIL-2R. The proliferation of the transduced cells was inhibited. Similarly, antibody to human IL-2 also inhibited the proliferation, further suggesting that the proliferation observed was caused by expression of the transgene. The lack of complete inhibition may have been caused by insufficient concentrations of blocking antibody. Alternatively, the secretion of IL-2 may result in greater interaction of the IL-2 with the IL-2 receptor. Incomplete blocking of proliferation by antibody to the murine IL-2 receptor was also observed in previous studies by Yamada et al.'' Increased IL-2 production was also measured in the presence of a blocking antimurine IL-2 receptor antibody, further demonstrating the expression of the IL-2 gene.
Studies have suggested that persistent, constitutive production of IL-2 by T lymphocytes may lead to the autocrine growth of these cell^^^'^ and this has been proposed as a mechanism leading to leukemogenesis by T This was suggested by the finding that in vitro growth of a human T-cell line isolated from a patient with non-Hodgkin's Tcell lymphoma was related to autocrine stimulation by IL-2.26 Also, the MLA 144 leukemia cell line constitutively produces IL-2, and its growth can be inhibited by agents that block IL-2 prod~ction.~'.~~ An autocrine loop has been suggested for the growth of adult T-cell leukemidlymphoma cells in which the IL-2 gene is transactivated by the human T lymphotropic virus-I.22
In the current studies, the growth of the T cells transduced with the SAM-IL-2EN and GIL-2EN vectors was ongoing for over 100 days, suggesting that these lines are also immortalized. Still, the transduced cells did not differ in morphology from that of the parent line, nor did the transduced cells form tumors when implanted subcutaneously in syngeneic BALB/c mice, suggesting that the tumorogenicity of these cells is low. Karasuyama et a19 also found no tumorigenicity by the helper T-cell line HT-2 transfected with the cDNA for IL-2, after subcutaneous or intraperitoneal injection of the cells into syngeneic or irradiated mice. In their studies tumor formation did occur in nude mice injected with the transfected clones secreting the highest amounts of IL-2. This may suggest a more complex interaction of IL-2 secreting T cells with other lymphocytes in situ, resulting in growth inhibition. Yamada et all" have also demonstrated that a murine cytotoxic T-cell line CTLL-2 infected with a retroviral vector carrying the cDNA for the human IL-2 resulted in proliferation in the absence of exogenous IL-2. In contrast to our findings, tumor formation by the IL-2-transduced CTLL line occurred even when injected into syngeneic mice.'" The potential for lymphogenesis, although quite low, suggest that for clinical application it may be necessary to insert a suicide gene along with the gene for IL-2 into T cells to be used for therapy.
The production of IL-2 by adoptively transferred T cells might serve to both maintain the cells in vivo as well as to enhance their ability to eliminate their target. Expression of IL-2 may provide a means for breaking tolerance, similar to that seen in a transgenic system.29 The retrovirally mediated expression of IL-2 by tumors can abrogate tumorigenicity and result in immunologic recognition of the tumor.'"." However, it has become increasingly evident that IL-2 may serve a variety of immunoregulatory functions, and the exposure of cells to IL-2 may result in altered function. Cloned helper T lymphocytes exposed to IL-2 may become unresponsive to antigen despite their ability to proliferate in response to IL-2." Antigen stimulation of lymphocytes proliferating in response to IL-2 may also result in apoptosis of the cells." In the present study we observed that the lymphocytes transduced with the IL-2 gene continued to recognize and remain responsive to the SWM antigen, as measured by the secretion of IFN-y. There also appeared to be no loss of specificity for the antigen. Nor was there any increase in the baseline production of IFN-y, suggesting that the cells, although proliferating, were not nonspecifically activated. Thus, it appeared that the constitutive production of IL-2 and the ability to grow in the absence of exogenous IL-2 did not interfere with antigen recognition or cytokine release by these transduced T cells.
Although this study shows the transduction and functional expression of an IL-2 containing vector into a CD4' T-cell line, the ability to transduce and express genes in CD8' lymphocytes has been difficult. As previously reported," the insertion of vectors coding for the tumor necrosis factor-cy gene into CD8' TIL has resulted in relatively low levels of expression compared with that of tumor lines. To date, the transduction of both human and murine CD8+ TIL with the IL-2 gene has resulted in little if any measurable IL-2 production and has not led to their constitutive growth. A variety of alternative approaches are currently being investigated that may not require high levels of gene expression and yet still potentially allow the growth of T cells without the use of the high doses of IL-2 that are currently required. The introduction into T cells of alternative cytokine receptors or chimeric receptors that bind ligands other than IL-2, yet signal through the IL-2 receptor, are currently being investigated. Still, the ability of IL-2-transduced T cells to grow in an autocrine fashion yet maintain their antigenic reactivity further suggests the potential utility of using lymphocytes genetically modified to constitutively produce IL-2 for the immunotherapy of tumors.
